kw.\*:("Survival benefit")
Results 1 to 14 of 14
Selection :
Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinomaYING JIN; XIN AN; YU CHEN CAI et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 10, pp 1545-1551, issn 0171-5216, 7 p.Article
Survival Benefit of Pancreaticoduodenectomy in a Japanese Fashion for a Limited Group of Patients with Pancreatic Head CancerTAKAO, Sonshin; SHINCHI, Hiroyuki; MAEMURA, Kosei et al.Hepato-gastroenterology. 2008, Vol 55, Num 86-87, pp 1789-1795, issn 0172-6390, 7 p.Article
The similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patientsKIM, Hye-Ryoun; MIN SOO KANG; IM IL NA et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 4, pp 547-552, issn 0171-5216, 6 p.Article
Role of regular follow-up after curative surgery for colorectal cancerBYUNG WOOK MIN; JUN WON UM; HONG YOUNG MOON et al.Hepato-gastroenterology. 2007, Vol 54, Num 73, pp 63-66, issn 0172-6390, 4 p.Article
Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysisSU JIN LEE; LEE, Jeeyun; HEE CHEOL KIM et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 2, pp 229-235, issn 0344-5704, 7 p.Article
Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastasesNIIBE, Yuzuru; KARASAWA, Katsuyuki; NAKAMURA, Osamu et al.Anticancer research. 2003, Vol 23, Num 5B, pp 4157-4159, issn 0250-7005, 3 p.Article
Disease-Specific Survival Benefit of Lung Transplantation in Adults: A National Cohort StudyTITMAN, A; ROGERS, C. A; BONSER, R. S et al.American journal of transplantation (Print). 2009, Vol 9, Num 7, pp 1640-1649, issn 1600-6135, 10 p.Article
Is response rate increment obtained by molecular targeted agents related to survival benefit in the phase III trials of advanced cancer?TSUJINO, K; SHIRAISHI, J; TSUJI, T et al.Annals of oncology. 2010, Vol 21, Num 8, pp 1668-1674, issn 0923-7534, 7 p.Article
Evaluating Options for Utility-Based Kidney AllocationSEGEV, D. L.American journal of transplantation (Print). 2009, Vol 9, Num 7, pp 1513-1518, issn 1600-6135, 6 p.Article
Valuation of contingent claims with mortality and interest rate risksJALEN, Luka; MAMON, Rogemar.Mathematical and computer modelling. 2009, Vol 49, Num 9-10, pp 1893-1904, issn 0895-7177, 12 p.Article
Survival gains needed to offset persistent adverse treatment effects in localised prostate cancerKING, M. T; VINEY, R; STRICKER, P et al.British journal of cancer. 2012, Vol 106, Num 4, pp 638-645, issn 0007-0920, 8 p.Article
The Survival Benefit of Deceased Donor Liver Transplantation as a Function of Candidate Disease Severity and Donor QualitySCHAUBEL, D. E; SIMA, C. S; GOODRICH, N. P et al.American journal of transplantation (Print). 2008, Vol 8, Num 2, pp 419-425, issn 1600-6135, 7 p.Article
Comparison of Gemcitabine Combined With Targeted Agent Therapy Versus Gemcitabine Monotherapy in the Management of Advanced Pancreatic CancerQIN LI; ZHENYAN YUAN; HAN YAN et al.Clinical therapeutics. 2014, Vol 36, Num 7, pp 1054-1063, issn 0149-2918, 10 p.Article
Are Patients With Child's A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?BERRY, K; IOANNOU, G. N.American journal of transplantation (Print). 2012, Vol 12, Num 3, pp 706-717, issn 1600-6135, 12 p.Article